HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER		Author Keyword(s) Vol Page [Advanced]

This Article Full Text Full Text (PDF) All Versions of this Article: jcp.2006.044891v1 60/12/1384    most recent Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this link to a friend Similar articles in this journal Similar articles in PubMed Add article to my folders Download to citation manager Request Permissions Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Riley, P Articles by Crook, M Search for Related Content PubMed PubMed Citation Articles by Riley, P Articles by Crook, M

A growing burden: the pathogenesis, investigation and management of non-alcoholic fatty liver disease

¹ Department of Gastroenterology, University Hospital Lewisham, London, UK
² Department of Biochemistry, University Hospital Lewisham, London, UK

Correspondence to:
Mr P Riley, Department of Gastroenterology, University Hospital Lewisham, Lewisham High Street, London SE13 6LH, UK; paul.riley{at}kcl.ac.uk

Non-alcoholic fatty liver disease (NAFLD) is the most common hepatic disorder in western countries, and its incidence is increasing. This review outlines the significant health burden posed by NAFLD and discusses what is presently known about its pathogenesis, including the roles of the metabolic syndrome, obesity, insulin resistance, hepatic steatosis, reactive oxygen species, inflammatory cytokines and adipocytokines. The way in which NAFLD is clinically diagnosed is described, and areas of uncertainty surrounding its investigation are identified, before discussing the relative merits of the limited treatment options available and looking ahead to potential therapeutic strategies for the future.